Endo inks $465M bankruptcy deal settling criminal and civil opioid cases
Endo agreed to pay up to $464.9 million to resolve claims around the marketing of its former opioid pain medication Opana ER.
The company this …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
